Effects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients With High Risk Hypertension
Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
Left ventricular hypertrophy (LVH) increases the risk of cardiovascular morbidity and
mortality in patients with high blood pressure, compared to those without LVH. Reduction of
left ventricular mass (LVM) with antihypertensive agents is associated with improved clinical
outcome. This study will evaluate the effects of amlodipine/benazepril in reducing LVM in
patients with high risk hypertension.